Invivyd Inc.

NASDAQ: IVVD
Share price (8/15/25): $0.71
Market cap (8/15/25): $85.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Exempt offering of securities

Shelf registration

Ownership Filter

Maverick Capital Ltd

McGuire Terrance

McLaughlin Kevin F

M28 Capital Management LP, Elia Marc

News Filter

Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome

Announces Positive Full Phase 1/2 Clinical Data for VYD2311, a Next Generation COVID-19 Monoclonal Antibody for Potential Use as a Non-Vaccine Preventative and for Treatment of Active Infection

Shareholder Vote Results

Reports First Quarter 2025 Financial Results and Recent Business Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Correspondence with the SEC

Letter from the SEC